Dr. Maryland Franklin has 20 years of experience with preclinical pharmacology models, more than half spent in biotech and pharma companies. Throughout her career, Dr. Franklin worked as a member of numerous multidisciplinary teams to deliver agents from research into development, and she was a key leader in bringing four drugs into Phase I clinical trials.
She started her industry career as a research scientist in the preclinical development group at ZymoGenetics, working on animal models of lung fibrosis, anti-virals, and psoriasis. In 2003, Dr. Franklin joined the In Vivo Pharmacology Department at OSI Pharmaceuticals, where she supervised the internal and external placement of oncology-focused in vivo pharmacology studies and established and managed external collaborations around target identification, biomarkers, animal models, and imaging.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)